首页> Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research> Prognostic Significance of Cytokine Release Syndrome in B Cell Hematological Malignancies Patients After Chimeric Antigen Receptor T Cell Therapy.

Prognostic Significance of Cytokine Release Syndrome in B Cell Hematological Malignancies Patients After Chimeric Antigen Receptor T Cell Therapy.

导出原文传递

翻译打印收藏纠错

第一作者： Rujiao,Dong

第一单位： Department of Hematology, Wenzhou Key Laboratory of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

作者： Rujiao,Dong ^[1] ; Songfu,Jiang ^[1] ; Yi,Chen ^[1] ; Yongyong,Ma ^[1] ; Lan,Sun ^[1] ; Chongyun,Xing ^[1] ; Shenghui,Zhang ^[2] ; Kang,Yu ^[1]

作者单位： Department of Hematology, Wenzhou Key Laboratory of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. ^[1] Department of Hematology, Wenzhou Key Laboratory of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.;Laboratory Animal Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. ^[2]

关键词 acute lymphoblastic leukemia chimeric antigen receptor T cells cytokine release syndrome non-Hodgkin lymphoma prognosis